Found: 19
Select item for more details and to access through your institution.
Phase I Clinical and Pharmacological Studies of 20-(S)-Camptothecin and 20-(S)-9-Nitrocamptothecin as Anticancer Agents.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 224, doi. 10.1111/j.1749-6632.1996.tb26392.x
- By:
- Publication type:
- Article
Inhibition of the chimeric DnaJ‐PKAc enzyme by endogenous inhibitor proteins.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 8, p. 13783, doi. 10.1002/jcb.28651
- By:
- Publication type:
- Article
Novel organometallic chloroquine derivative inhibits tumor growth.
- Published in:
- Journal of Cellular Biochemistry, 2018, v. 119, n. 7, p. 5921, doi. 10.1002/jcb.26787
- By:
- Publication type:
- Article
Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumors.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 266, doi. 10.1038/s41416-023-02280-4
- By:
- Publication type:
- Article
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Maturation of dendritic cells from ovarian cancer patients.
- Published in:
- 2001
- By:
- Publication type:
- journal article
When Clinical Trial Participation Is Not an Option in the Era of Personalized Medicine: The Case of Two Patients.
- Published in:
- Oncology, 2017, v. 92, n. 1, p. 55, doi. 10.1159/000450712
- By:
- Publication type:
- Article
Recombinant Human Thrombopoietin Attenuates Carboplatin-Induced Severe Thrombocytopenia and the Need for Platelet Transfusions in Patients with Gynecologic Cancer.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 10, p. 2541, doi. 10.1007/s00432-019-02982-4
- By:
- Publication type:
- Article
Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor Cells.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e487, doi. 10.1016/j.cllc.2020.10.018
- By:
- Publication type:
- Article
Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low‐molecular‐weight heparin.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 938, doi. 10.1002/cncr.33337
- By:
- Publication type:
- Article
Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor.
- Published in:
- Proteomics, 2003, v. 3, n. 10, p. 1904, doi. 10.1002/pmic.200300547
- By:
- Publication type:
- Article
A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma.
- Published in:
- Cancers, 2013, v. 5, n. 2, p. 418, doi. 10.3390/cancers5020418
- By:
- Publication type:
- Article
Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 287, doi. 10.1007/s00280-008-0869-5
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 903, doi. 10.1007/s00280-008-0813-8
- By:
- Publication type:
- Article
The breakpoint cluster region site in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix.
- Published in:
- 2001
- By:
- Publication type:
- journal article